How to manage if there is a shortage of your epilepsy medication
We are receiving many calls to our Helpline alongside online enquiries from people who are experiencing difficulties in getting their epilepsy medication. Here, our medical director Professor Ley Sander looks at the problem and explains what you can do to manage the situation and how the Government is tackling current shortages.
Shortage of Epanutin Infatabs 50 mg
We have been advised by the pharmaceutical company Pfizer that due to manufacturing delays there will be a shortage of Epanutin (phenytoin) Infatabs 50mg from 1 May through to July or August 2019.
All dosages of Epilim are now back in stock
Following on from our news story on 1 February 2019, we have been informed by Sanofi that all doses and formulations of Epilim (sodium valproate) are currently in stock in the UK.
Teva to discontinue Oxcarbazepine 150mg tablets
Teva UK are discontinuing their version of Oxcarbazepine 150mg tablets in October 2019. There is currently stock available. They have already discontinued their 300mg and 600mg tablets.
Pregabalin and Gabapentin have been re-classified as class 3 controlled drugs
If you have been prescribed gabapentin (Neurontin) or pregabalin (Alzain or Lyrica), it is important to be aware that the law is changing from 1 April 2019 and these medications are being re-classified as controlled drugs.
Award-winning playwright to perform a show about living with someone who has epilepsy
Update: 12 March 2019
Our Marketing and Communications Executive, Paige Dawkins, went to see Dangerous Giant Animals at the weekend. Here, she reviews the play.